Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2008

Open Access 01-07-2008 | Research

Increased chemotactic migration and growth in heparanase-overexpressing human U251n glioma cells

Authors: Xin Hong, Feng Jiang, Steven N Kalkanis, Zheng Gang Zhang, Xuepeng Zhang, Xuguang Zheng, Hao Jiang, Tom Mikkelsen, Michael Chopp

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2008

Login to get access

Abstract

Heparanase is an endoglycosidase that degrades heparan sulfate, the main polysaccharide constituent of the extracellular matrix (ECM) and basement membrane. Expression of the heparanase gene is associated with the invasion and metastatic potential of a variety of tumor-derived cell types. However, the roles of heparanase in the regulation of gene expression and the subsequent cell function changes other than invasion are not clear. In the current study, we overexpressed the human heparanase gene in a human U251n glioma cell line. We found that heparanase-overexpression significantly increased cell invasion, proliferation, anchorage-independent colony formation and chemotactic migration towards fetal bovine serum (FBS)-supplied medium and stromal cell-derived factor-1 (SDF-1). These phenotypic appearances were accompanied by enhanced protein kinase B (AKT) phosphorylation. Focal adhesion kinase (FAK) and extracellular signal-regulated kinase 1 (ERK1) signaling were not altered by heparanase-overexpression. These results indicate that heparanase has pleiotropic effects on tumor cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Liotta LA, Kohn EC: The microenvironment of the tumour-host interface. Nature. 2001, 411 (6835): 375-379. 10.1038/35077241.CrossRef Liotta LA, Kohn EC: The microenvironment of the tumour-host interface. Nature. 2001, 411 (6835): 375-379. 10.1038/35077241.CrossRef
2.
go back to reference Kalluri R: Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer. 2003, 3 (6): 422-433. 10.1038/nrc1094.CrossRef Kalluri R: Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer. 2003, 3 (6): 422-433. 10.1038/nrc1094.CrossRef
3.
go back to reference David G, Bernfield M: The emerging roles of cell surface heparan sulfate proteoglycans. Matrix Biol. 1998, 17 (7): 461-463. 10.1016/S0945-053X(98)90092-0.CrossRef David G, Bernfield M: The emerging roles of cell surface heparan sulfate proteoglycans. Matrix Biol. 1998, 17 (7): 461-463. 10.1016/S0945-053X(98)90092-0.CrossRef
4.
go back to reference Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, Pecker I: Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med. 1999, 5 (7): 793-802. 10.1038/10518.CrossRef Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, Pecker I: Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med. 1999, 5 (7): 793-802. 10.1038/10518.CrossRef
5.
go back to reference Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, Parish CR: Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med. 1999, 5 (7): 803-809. 10.1038/10525.CrossRef Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, Parish CR: Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med. 1999, 5 (7): 803-809. 10.1038/10525.CrossRef
6.
go back to reference Kussie PH, Hulmes JD, Ludwig DL, Patel S, Navarro EC, Seddon AP, Giorgio NA, Bohlen P: Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun. 1999, 261 (1): 183-187. 10.1006/bbrc.1999.0962.CrossRef Kussie PH, Hulmes JD, Ludwig DL, Patel S, Navarro EC, Seddon AP, Giorgio NA, Bohlen P: Cloning and functional expression of a human heparanase gene. Biochem Biophys Res Commun. 1999, 261 (1): 183-187. 10.1006/bbrc.1999.0962.CrossRef
7.
go back to reference Toyoshima M, Nakajima M: Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem. 1999, 274 (34): 24153-24160. 10.1074/jbc.274.34.24153.CrossRef Toyoshima M, Nakajima M: Human heparanase. Purification, characterization, cloning, and expression. J Biol Chem. 1999, 274 (34): 24153-24160. 10.1074/jbc.274.34.24153.CrossRef
8.
go back to reference Vlodavsky I, Friedmann Y: Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest. 2001, 108 (3): 341-347.CrossRef Vlodavsky I, Friedmann Y: Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest. 2001, 108 (3): 341-347.CrossRef
9.
go back to reference Parish CR, Freeman C, Hulett MD: Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta. 2001, 1471 (3): M99-108. Parish CR, Freeman C, Hulett MD: Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta. 2001, 1471 (3): M99-108.
10.
go back to reference Ikeguchi M, Ueta T, Yamane Y, Hirooka Y, Kaibara N: Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma. J Surg Oncol. 2002, 81 (3): 148-54; disscusion 154. 10.1002/jso.10163.CrossRef Ikeguchi M, Ueta T, Yamane Y, Hirooka Y, Kaibara N: Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma. J Surg Oncol. 2002, 81 (3): 148-54; disscusion 154. 10.1002/jso.10163.CrossRef
11.
go back to reference Tang W, Nakamura Y, Tsujimoto M, Sato M, Wang X, Kurozumi K, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K: Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Mod Pathol. 2002, 15 (6): 593-598. 10.1038/modpathol.3880571.CrossRef Tang W, Nakamura Y, Tsujimoto M, Sato M, Wang X, Kurozumi K, Nakahara M, Nakao K, Nakamura M, Mori I, Kakudo K: Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Mod Pathol. 2002, 15 (6): 593-598. 10.1038/modpathol.3880571.CrossRef
12.
go back to reference Gohji K, Okamoto M, Kitazawa S, Toyoshima M, Dong J, Katsuoka Y, Nakajima M: Heparanase protein and gene expression in bladder cancer. J Urol. 2001, 166 (4): 1286-1290. 10.1016/S0022-5347(05)65754-0.CrossRef Gohji K, Okamoto M, Kitazawa S, Toyoshima M, Dong J, Katsuoka Y, Nakajima M: Heparanase protein and gene expression in bladder cancer. J Urol. 2001, 166 (4): 1286-1290. 10.1016/S0022-5347(05)65754-0.CrossRef
13.
go back to reference Ikuta M, Podyma KA, Maruyama K, Enomoto S, Yanagishita M: Expression of heparanase in oral cancer cell lines and oral cancer tissues. Oral Oncol. 2001, 37 (2): 177-184. 10.1016/S1368-8375(00)00077-4.CrossRef Ikuta M, Podyma KA, Maruyama K, Enomoto S, Yanagishita M: Expression of heparanase in oral cancer cell lines and oral cancer tissues. Oral Oncol. 2001, 37 (2): 177-184. 10.1016/S1368-8375(00)00077-4.CrossRef
14.
go back to reference Friedmann Y, Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I, Pappo O: Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol. 2000, 157 (4): 1167-1175.CrossRef Friedmann Y, Vlodavsky I, Aingorn H, Aviv A, Peretz T, Pecker I, Pappo O: Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol. 2000, 157 (4): 1167-1175.CrossRef
15.
go back to reference Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, Pecker I, Vlodavsky I, Zimmermann A, Buchler MW: Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res. 2001, 61 (12): 4655-4659. Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, Pecker I, Vlodavsky I, Zimmermann A, Buchler MW: Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res. 2001, 61 (12): 4655-4659.
16.
go back to reference Rohloff J, Zinke J, Schoppmeyer K, Tannapfel A, Witzigmann H, Mossner J, Wittekind C, Caca K: Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br J Cancer. 2002, 86 (8): 1270-1275. 10.1038/sj.bjc.6600232.CrossRef Rohloff J, Zinke J, Schoppmeyer K, Tannapfel A, Witzigmann H, Mossner J, Wittekind C, Caca K: Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma. Br J Cancer. 2002, 86 (8): 1270-1275. 10.1038/sj.bjc.6600232.CrossRef
17.
go back to reference Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I: A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol. 1988, 130 (2): 393-400. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I: A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. Am J Pathol. 1988, 130 (2): 393-400.
18.
go back to reference Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M: Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A. 1987, 84 (8): 2292-2296. 10.1073/pnas.84.8.2292.CrossRef Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M: Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A. 1987, 84 (8): 2292-2296. 10.1073/pnas.84.8.2292.CrossRef
19.
go back to reference Schubert SY, Ilan N, Shushy M, Ben-Izhak O, Vlodavsky I, Goldshmidt O: Human heparanase nuclear localization and enzymatic activity. Lab Invest. 2004, 84 (5): 535-544. 10.1038/labinvest.3700084.CrossRef Schubert SY, Ilan N, Shushy M, Ben-Izhak O, Vlodavsky I, Goldshmidt O: Human heparanase nuclear localization and enzymatic activity. Lab Invest. 2004, 84 (5): 535-544. 10.1038/labinvest.3700084.CrossRef
20.
go back to reference Zetser A, Bashenko Y, Miao HQ, Vlodavsky I, Ilan N: Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res. 2003, 63 (22): 7733-7741. Zetser A, Bashenko Y, Miao HQ, Vlodavsky I, Ilan N: Heparanase affects adhesive and tumorigenic potential of human glioma cells. Cancer Res. 2003, 63 (22): 7733-7741.
21.
go back to reference Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N: Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res. 2006, 66 (3): 1455-1463. 10.1158/0008-5472.CAN-05-1811.CrossRef Zetser A, Bashenko Y, Edovitsky E, Levy-Adam F, Vlodavsky I, Ilan N: Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation. Cancer Res. 2006, 66 (3): 1455-1463. 10.1158/0008-5472.CAN-05-1811.CrossRef
22.
go back to reference Sotnikov I, Hershkoviz R, Grabovsky V, Ilan N, Cahalon L, Vlodavsky I, Alon R, Lider O: Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts. J Immunol. 2004, 172 (9): 5185-5193.CrossRef Sotnikov I, Hershkoviz R, Grabovsky V, Ilan N, Cahalon L, Vlodavsky I, Alon R, Lider O: Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts. J Immunol. 2004, 172 (9): 5185-5193.CrossRef
23.
go back to reference Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang XP, DeCarvalho AC, Katakowski M, Bobbitt K, Mikkelsen T, Chopp M: SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. Cancer Lett. 2006, 236 (1): 39-45. 10.1016/j.canlet.2005.05.011.CrossRef Hong X, Jiang F, Kalkanis SN, Zhang ZG, Zhang XP, DeCarvalho AC, Katakowski M, Bobbitt K, Mikkelsen T, Chopp M: SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion. Cancer Lett. 2006, 236 (1): 39-45. 10.1016/j.canlet.2005.05.011.CrossRef
24.
go back to reference Nakada M, Okada Y, Yamashita J: The role of matrix metalloproteinases in glioma invasion. Front Biosci. 2003, 8: e261-9. 10.2741/1016.CrossRef Nakada M, Okada Y, Yamashita J: The role of matrix metalloproteinases in glioma invasion. Front Biosci. 2003, 8: e261-9. 10.2741/1016.CrossRef
25.
go back to reference Barbero S, Bajetto A, Bonavia R, Porcile C, Piccioli P, Pirani P, Ravetti JL, Zona G, Spaziante R, Florio T, Schettini G: Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann N Y Acad Sci. 2002, 973: 60-69.CrossRef Barbero S, Bajetto A, Bonavia R, Porcile C, Piccioli P, Pirani P, Ravetti JL, Zona G, Spaziante R, Florio T, Schettini G: Expression of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1 in human brain tumors and their involvement in glial proliferation in vitro. Ann N Y Acad Sci. 2002, 973: 60-69.CrossRef
26.
go back to reference Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001, 410 (6824): 50-56. 10.1038/35065016.CrossRef Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001, 410 (6824): 50-56. 10.1038/35065016.CrossRef
27.
go back to reference Zhou Y, Larsen PH, Hao C, Yong VW: CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem. 2002, 277 (51): 49481-49487. 10.1074/jbc.M206222200.CrossRef Zhou Y, Larsen PH, Hao C, Yong VW: CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem. 2002, 277 (51): 49481-49487. 10.1074/jbc.M206222200.CrossRef
28.
go back to reference Miao HQ, Elkin M, Aingorn E, Ishai-Michaeli R, Stein CA, Vlodavsky I: Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int J Cancer. 1999, 83 (3): 424-431. 10.1002/(SICI)1097-0215(19991029)83:3<424::AID-IJC20>3.0.CO;2-L.CrossRef Miao HQ, Elkin M, Aingorn E, Ishai-Michaeli R, Stein CA, Vlodavsky I: Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int J Cancer. 1999, 83 (3): 424-431. 10.1002/(SICI)1097-0215(19991029)83:3<424::AID-IJC20>3.0.CO;2-L.CrossRef
29.
go back to reference Naggi A, Casu B, Perez M, Torri G, Cassinelli G, Penco S, Pisano C, Giannini G, Ishai-Michaeli R, Vlodavsky I: Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting. J Biol Chem. 2005, 280 (13): 12103-12113. 10.1074/jbc.M414217200.CrossRef Naggi A, Casu B, Perez M, Torri G, Cassinelli G, Penco S, Pisano C, Giannini G, Ishai-Michaeli R, Vlodavsky I: Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting. J Biol Chem. 2005, 280 (13): 12103-12113. 10.1074/jbc.M414217200.CrossRef
30.
go back to reference Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB: Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res. 1999, 59 (14): 3433-3441. Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB: Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res. 1999, 59 (14): 3433-3441.
31.
go back to reference Lapierre F, Holme K, Lam L, Tressler RJ, Storm N, Wee J, Stack RJ, Castellot J, Tyrrell DJ: Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. Glycobiology. 1996, 6 (3): 355-366. 10.1093/glycob/6.3.355.CrossRef Lapierre F, Holme K, Lam L, Tressler RJ, Storm N, Wee J, Stack RJ, Castellot J, Tyrrell DJ: Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. Glycobiology. 1996, 6 (3): 355-366. 10.1093/glycob/6.3.355.CrossRef
32.
go back to reference Toker A, Yoeli-Lerner M: Akt signaling and cancer: surviving but not moving on. Cancer Res. 2006, 66 (8): 3963-3966. 10.1158/0008-5472.CAN-06-0743.CrossRef Toker A, Yoeli-Lerner M: Akt signaling and cancer: surviving but not moving on. Cancer Res. 2006, 66 (8): 3963-3966. 10.1158/0008-5472.CAN-06-0743.CrossRef
33.
go back to reference Doviner V, Maly B, Kaplan V, Gingis-Velitski S, Ilan N, Vlodavsky I, Sherman Y: Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence. Mod Pathol. 2006, 19 (6): 878-888. Doviner V, Maly B, Kaplan V, Gingis-Velitski S, Ilan N, Vlodavsky I, Sherman Y: Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence. Mod Pathol. 2006, 19 (6): 878-888.
34.
go back to reference Werbowetski-Ogilvie TE, Agar NY, Waldkircher de Oliveira RM, Faury D, Antel JP, Jabado N, Del Maestro RF: Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2. Cancer Res. 2006, 66 (3): 1464-1472. 10.1158/0008-5472.CAN-05-1913.CrossRef Werbowetski-Ogilvie TE, Agar NY, Waldkircher de Oliveira RM, Faury D, Antel JP, Jabado N, Del Maestro RF: Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2. Cancer Res. 2006, 66 (3): 1464-1472. 10.1158/0008-5472.CAN-05-1913.CrossRef
35.
go back to reference Giese A, Westphal M: Glioma invasion in the central nervous system. Neurosurgery. 1996, 39 (2): 235-50; discussion 250-2. 10.1097/00006123-199608000-00001.CrossRef Giese A, Westphal M: Glioma invasion in the central nervous system. Neurosurgery. 1996, 39 (2): 235-50; discussion 250-2. 10.1097/00006123-199608000-00001.CrossRef
Metadata
Title
Increased chemotactic migration and growth in heparanase-overexpressing human U251n glioma cells
Authors
Xin Hong
Feng Jiang
Steven N Kalkanis
Zheng Gang Zhang
Xuepeng Zhang
Xuguang Zheng
Hao Jiang
Tom Mikkelsen
Michael Chopp
Publication date
01-07-2008
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2008
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-27-23

Other articles of this Issue 1/2008

Journal of Experimental & Clinical Cancer Research 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine